SLSN Solesence Inc: Price-to-Projected Revenue Ratio

Solesence Inc. - graphic logo of issuer SLSN

Solesence Inc is scaling the implementation of its patented mineral protection systems within the luxury segment. The shift in forward P/S allows for the filtering of market noise and an assessment of the real value of revenue, accounting for currency factors. Business revenues are based on B2B supplies of unique UV filters. Its status as a dermatology innovator ensures the trust of major corporations, while the 1.20 mark reflects the latest data.

Solesence Beauty - SLSN Market Cap to Future Revenue Ratio (period 04/09/2025 - 11/13/2026)

SLSN (solesence.com): analytical breakdowns and indicator data

- market price and analyst price targets:
Price Chart Solesence|SLSN - Average Forecast Price
- company stock capitalization data:
Market Value SLSN|SLSN - Total Company Value
- book value of equity indicators:
Book Value per Share Solesence Inc|SLSN - Total Stockholders' Equity|Market Value to Book Value Ratio solesence.com|SLSN - Company Total Asset Base
- business debt structure and liquidity details:
Total Debt to Capital Solesence Inc|SLSN - Long-Term Liabilities to Capital|Short-Term Debt to Equity Solesence|SLSN - Company Aggregate Debt|Debts to Book Capitalization SLSN|SLSN - Company Long-Term Liabilities|Company Short-Term Debts Solesence Inc|Quick Liquidity Indicator solesence.com
- financial results and valuation multiples details:
SLSN - Final Profit|Projected Future Earnings Solesence Inc|SLSN - Business Payback Period|Future Price to Earnings Solesence|SLSN - Growth-Adjusted P/E Ratio|EV/EBITDA Multiple SLSN|SLSN - Operating profit before deduction of amortization|Earnings per share for the last twelve months Solesence Inc|SLSN - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months solesence.com|SLSN - Earnings per share growth in current year|Net earnings per share growth forecast for next year Solesence Inc
- revenue and sales details:
SLSN - Company Gross Revenue|Company Projected Revenue Solesence|SLSN - Market Cap to Revenue Ratio|Price-to-Projected Revenue Ratio SLSN
Fundamental company valuation:Solesence Inc. SLSN
Product sample of Solesence

Forward P/S compares current market capitalization with expected revenue for the following year, allowing for an assessment of the premium paid for future sales growth. By analyzing the projected P/S trend, an investor can identify an overvalued asset amid prolonged formulation approvals in the B2B sector and strict FDA requirements, which critically impact the scaling pace of Solesence Inc (SLSN).

Competitors of Solesence Inc (SLSN)

Price-to-Projected Revenue Ratio Krystal Biotech KRYS|Apogee Therapeutics Inc (APGE) - Market Cap to Future Revenue Ratio|ARQT - Price-to-Projected Revenue Ratio|VCEL: Price-to-Projected Revenue Ratio|ORKA: Forward P/S Multiple|Market Cap to Future Revenue Ratio Sanara MedTech (SMTI)|Price-to-Projected Revenue Ratio DBV Tech|Journey Medical Corp. (DERM) - Market Cap to Expected Sales Ratio|Forward P/S Multiple FBRX|EMPG - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Sol-Gel Technologies SLGL|AXIL: Market Cap to Projected Revenue|Medicus Pharma - Forward P/S Multiple|Verrica Pharmaceuticals (VRCA) - Forward Price-to-Revenue Multiple|HOTH: Forward P/S Multiple|Market Cap to Future Revenue Ratio Biofrontera (BFRI)|Forward Price-to-Revenue Multiple VYNE|SNOA: Forward Price to Sales|Forward P/S Multiple QNRX|Market Cap to Expected Sales Ratio Azitra Inc|Price-to-Projected Revenue Ratio Dermata DRMA|ELAB: Market Cap to Projected Revenue|Revance Therapeutics - Forward P/S Multiple